Literature DB >> 30190968

The biological and clinical challenge of liver cancer heterogeneity.

Xin Wei Wang1,1, Snorri S Thorgeirsson2,2.   

Abstract

Entities:  

Keywords:  cholangiocarcinoma; hepatocellular carcinoma; molecular subtype; precision cancer medicine; tumor genomics heterogeneity

Year:  2014        PMID： 30190968      PMCID： PMC6096446          DOI： 10.2217/hep.14.18

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  28 in total

1.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

Review 2.  Gene signatures in the management of hepatocellular carcinoma.

Authors:  Yujin Hoshida; Agrin Moeini; Clara Alsinet; Kensuke Kojima; Augusto Villanueva
Journal:  Semin Oncol       Date:  2012-08       Impact factor: 4.929

3.  Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.

Authors:  Anuradha Budhu; Stephanie Roessler; Xuelian Zhao; Zhipeng Yu; Marshonna Forgues; Junfang Ji; Edward Karoly; Lun-Xiu Qin; Qing-Hai Ye; Hu-Liang Jia; Jia Fan; Hui-Chuan Sun; Zhao-You Tang; Xin Wei Wang
Journal:  Gastroenterology       Date:  2013-01-31       Impact factor: 22.682

Review 4.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

5.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

6.  Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

Authors:  Armando Santoro; Lorenza Rimassa; Ivan Borbath; Bruno Daniele; Stefania Salvagni; Jean Luc Van Laethem; Hans Van Vlierberghe; Jörg Trojan; Frank T Kolligs; Alan Weiss; Steven Miles; Antonio Gasbarrini; Monica Lencioni; Luca Cicalese; Morris Sherman; Cesare Gridelli; Peter Buggisch; Guido Gerken; Roland M Schmid; Corrado Boni; Nicola Personeni; Ziad Hassoun; Giovanni Abbadessa; Brian Schwartz; Reinhard Von Roemeling; Maria E Lamar; Yinpu Chen; Camillo Porta
Journal:  Lancet Oncol       Date:  2012-11-20       Impact factor: 41.316

7.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

8.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

9.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.

Authors:  Simon A Forbes; Nidhi Bindal; Sally Bamford; Charlotte Cole; Chai Yin Kok; David Beare; Mingming Jia; Rebecca Shepherd; Kenric Leung; Andrew Menzies; Jon W Teague; Peter J Campbell; Michael R Stratton; P Andrew Futreal
Journal:  Nucleic Acids Res       Date:  2010-10-15       Impact factor: 16.971

10.  Deciphering cancer heterogeneity: the biological space.

Authors:  Stephanie Roessler; Anuradha Budhu; Xin W Wang
Journal:  Front Cell Dev Biol       Date:  2014-04-03
View more
  17 in total

Review 1.  Roles of mitochondria in liver cancer stem cells.

Authors:  Ching-Wen Chang; Jeng-Fan Lo; Xin Wei Wang
Journal:  Differentiation       Date:  2019-05-30       Impact factor: 3.880

2.  The importance of integrated genomics to uncover clinically relevant cancer driver genes.

Authors:  Xuelian Zhao; Sonya Parpart-Li; Xin Wei Wang
Journal:  Mol Cell Oncol       Date:  2015-07-28

3.  Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma.

Authors:  Atsushi Takai; Hien Dang; Naoki Oishi; Subreen Khatib; Sean P Martin; Dana A Dominguez; Ji Luo; Rachel Bagni; Xiaolin Wu; Katie Powell; Qing-Hai Ye; Hu-Liang Jia; Lun-Xiu Qin; Jinqiu Chen; Gary A Mitchell; Xiaoling Luo; Snorri S Thorgeirsson; Xin Wei Wang
Journal:  Cancer Res       Date:  2019-03-12       Impact factor: 12.701

Review 4.  Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report.

Authors:  Jennifer Cable; Duanqing Pei; Lola M Reid; Xin Wei Wang; Sonam Bhatia; Panagiotis Karras; Jan Joseph Melenhorst; Markus Grompe; Justin D Lathia; Erwei Song; Calvin J Kuo; Ning Zhang; Richard M White; Stephanie Ky Ma; Lichun Ma; Y Rebecca Chin; Michael M Shen; Irene Oi Lin Ng; Klaus H Kaestner; Lei Zhou; Shaheen Sikandar; Clemens A Schmitt; Wei Guo; Carmen Chak-Lui Wong; Junfang Ji; Dean G Tang; Anna Dubrovska; Chunzhang Yang; Wolf R Wiedemeyer; Irving L Weissman
Journal:  Ann N Y Acad Sci       Date:  2021-11-30       Impact factor: 6.499

5.  Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer.

Authors:  Lichun Ma; Maria O Hernandez; Yongmei Zhao; Monika Mehta; Bao Tran; Michael Kelly; Zachary Rae; Jonathan M Hernandez; Jeremy L Davis; Sean P Martin; David E Kleiner; Stephen M Hewitt; Kris Ylaya; Bradford J Wood; Tim F Greten; Xin Wei Wang
Journal:  Cancer Cell       Date:  2019-10-03       Impact factor: 31.743

6.  Electromagnetic Tracking and Optical Molecular Imaging Guidance for Liver Biopsy and Point-of-Care Tissue Assessment in Phantom and Woodchuck Hepatocellular Carcinoma.

Authors:  Quirina M B de Ruiter; Sheng Xu; Ming Li; William F Pritchard; Matthew F Starost; Armando Filie; Andrew S Mikhail; Michal Mauda-Havakuk; Juan A Esparza-Trujillo; Ivane Bakhutashvili; Pedram Heidari; Umar Mahmood; John W Karanian; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2021-05-21       Impact factor: 2.797

7.  Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Lichun Ma; Limin Wang; Subreen A Khatib; Ching-Wen Chang; Sophia Heinrich; Dana A Dominguez; Marshonna Forgues; Julián Candia; Maria O Hernandez; Michael Kelly; Yongmei Zhao; Bao Tran; Jonathan M Hernandez; Jeremy L Davis; David E Kleiner; Bradford J Wood; Tim F Greten; Xin Wei Wang
Journal:  J Hepatol       Date:  2021-06-30       Impact factor: 25.083

Review 8.  Overcoming biological barriers to improve solid tumor immunotherapy.

Authors:  Anvay Ukidve; Katharina Cu; Ninad Kumbhojkar; Joerg Lahann; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2021-02-20       Impact factor: 4.617

Review 9.  Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.

Authors:  Alphonse E Sirica; Gregory J Gores; John D Groopman; Florin M Selaru; Mario Strazzabosco; Xin Wei Wang; Andrew X Zhu
Journal:  Hepatology       Date:  2019-03-25       Impact factor: 17.298

10.  Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.

Authors:  Valerie Fako; Zhipeng Yu; Curtis J Henrich; Tanya Ransom; Anuradha S Budhu; Xin W Wang
Journal:  Int J Biol Sci       Date:  2016-04-28       Impact factor: 6.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.